MedMira

MedMira is a Canadian biotechnology company dedicated to improving human health

with our patented Rapid Vertical Flow (RVF) Technology™ platform and rapid testing

solutions. RVF Technology enables best-in-class speed, multiplex results, and versatility

in any setting.

RVF Technology is the basis for MedMira’s commercialized product range that helps

healthcare providers and agencies combat COVID-19, HIV, hepatitis, syphilis, and other infectious

and sexually transmitted diseases. We have also established a research product line

that facilitates technology licensing, contract manufacturing, and regulatory consulting

revenue streams by enabling other researchers and collaborators to access MedMira

RVF Technology for the development and commercialization of new rapid tests.

Faced with decreasing budgets and resources, healthcare providers require high quality

rapid tests that deliver efficiency in every way, from performance to results. With the

unique capability of enabling multiplex results on one test device with just one drop of

specimen, we are delivering a new class of rapid testing solutions to our customers.

Our technology platform is a practical and scalable innovation that has the potential to

improve the wellbeing of people around the world. RVF Technology is the core engine

behind our world-class rapid testing solutions for infectious, sexually transmitted

diseases and other chronic healthcare conditions.

Speed and multiplexing are the hallmarks of our technology, which has endured the

most rigorous medical device approval processes in the world and validated by

healthcare providers, governments, and aid organizations. Our technology has been

proven in highly complex regulatory markets around the world including the United

States (FDA), Canada (Health Canada), Europe (CE) and China (CFDA).